Key Stats for JPMorgan Stock
- 52-Week Range: $256 to $337
- Current Price: $302
- Street Mean Target: $
- Street High Target: $
- Analyst Consensus: 8 Buys / 5 Outperforms / 12 Holds / 1 No Opinion
- TIKR Model Target (Dec. 2030): $400
What Happened?
JPMorgan Chase (JPM), the largest U.S. bank by assets, reported one of the strongest quarterly earnings prints in its history, with Q1 2026 EPS of $5.94 beating Wall Street’s $5.51 estimate by 7.78%.
Revenue of $49.84 billion rose 10% year-over-year, driven by a Markets business that has become one of the firm’s most powerful earnings levers.
The Corporate and Investment Bank (CIB), which houses JPM’s trading and advisory operations, delivered revenue of $23.4 billion, up 19% year-over-year, powered by fixed income markets revenue rising 21% and equities climbing 17%.
Investment banking fees surged 28% year-over-year, with M&A and equity underwriting driving the outperformance even as debt underwriting modestly lagged.
Chief Financial Officer Jeremy Barnum even stated on the Q1 2026 earnings call that “notwithstanding the recent volatility in market and gas prices based on our data, consumers and small businesses remain resilient with consumer spend growth continuing above last year’s pace,” reinforcing that credit quality across JPM’s $19.6 billion Consumer and Community Banking segment remains intact.
Net income reached $16.1 billion, producing a return on tangible common equity of 23%, and the firm maintained a CET1 capital ratio of 14.3% while sitting on approximately $40 billion in excess capital that management has explicitly said it would prefer to deploy into client relationships rather than buybacks at current prices.
Wall Street’s Take on JPM Stock
The Q1 beat resets the earnings baseline for the full year: JPMorgan Chase stock had been priced for a slowdown that the numbers show is not materializing, and a $5.94 EPS quarter forces a recalibration of what the full-year run rate actually looks like.
JPM’s normalized EPS reached $5.94 in Q1, up 17.2% year-over-year versus the year-ago $5.07, with consensus now building in around $5.40 for Q2 and roughly $5.82 by Q1 2027, anchored by IB fee momentum and a Markets business running at historically elevated volumes.
Of 26 analysts covering JPMorgan Chase stock, 13 carry Buy or Outperform ratings, 12 hold Holds, and just one carries a No Opinion, with a mean price target of $342 implying roughly 13% upside from current levels as analysts digest the strength of the CIB franchise.
The target spread runs from $295 at the low end to $391 at the high, a $96 range that reflects a genuine debate: bears point to expense growth of 14% year-over-year and the Basel III G-SIB reproposal, which management estimates could require approximately $20 billion of additional capital by 2028, while bulls argue the earnings power demonstrated this quarter makes those headwinds manageable.
The signal worth watching is management’s language around the $103 billion total NII guide for 2026: Barnum explicitly held it flat despite being asset-sensitive in a higher-rate environment, signaling conservative discipline rather than stretch, which historically precedes upside revisions.
Expense growth accelerating to 14% year-over-year is the model assumption most at risk if Markets revenue normalizes in the back half of 2026.
Q2 2026 earnings, where consensus expects around $5.40 in normalized EPS, will confirm whether the IB fee pipeline Barnum described as “resilient, maybe surprisingly resilient” actually holds through the quarter.
Financials
JPMorgan Chase’s Net Interest Income reached $25.37 billion in Q1 2026, up 9% year-over-year from $23.27 billion in Q1 2025, the strongest NII growth rate the firm has posted in six quarters.
The acceleration reflects balance sheet growth in the Markets business alongside moderating deposit yield-seeking behavior in consumer, with average deposits rising 2% year-over-year as account growth stabilized revolving balances that had been compressing NII in prior periods.
Total Revenues after provision for loan losses climbed 12.7% year-over-year to $47.33 billion in Q1 2026, extending a recovery from the prior-year trough when revenues fell 10.6% in Q2 2025, and pointing to a firm whose top-line trajectory has firmly reversed course.
The one tension in the income statement is that Non Interest Income’s trading-driven volatility makes the revenue base less predictable quarter to quarter: Income from Trading Activities hit $7.99 billion in Q1 2026, the highest figure in the data set, which provides a high comparison point that Q2 and Q3 will need to hold against.
What Does the Valuation Model Say?
TIKR’s mid-case model pegs JPMorgan Chase at a target price of around $400 by the end of 2026 based on a revenue CAGR assumption of around 4% and a net income margin of roughly 30%, inputs that the Q1 2026 actual net income margin of 32% already exceeds.
A $302 stock with a TIKR mid-case of $400 and a current-quarter net income margin running ahead of the model’s central assumption leaves JPMorgan Chase stock appearing undervalued, with the primary question being whether CIB revenue momentum can sustain into the second half rather than whether the core franchise deserves a higher price.
The investment case for JPMorgan Chase stock hinges on one question: can the CIB’s Markets and IB fee engines hold their pace, or was Q1 a peak-cycle print that the back half of 2026 cannot repeat?
The Case For:
- Q1 2026 EPS of $5.94 beat the $5.51 consensus estimate by 7.78%, with net income of $16.1 billion and ROTCE of 23% showing earnings power well above the firm’s own historical averages
- IB fees rose 28% year-over-year driven by M&A and equity underwriting; Barnum characterized the pipeline as “resilient, maybe surprisingly resilient” heading into Q2
- Total NII guidance of approximately $103 billion for full-year 2026 was held firm even as rates moved higher, suggesting management conservatism that has historically been followed by upside
- Approximately $40 billion in excess capital above regulatory requirements provides a buffer against Basel III G-SIB cost increases estimated at around $20 billion by 2028, with the remainder available for deployment or return
- Consumer credit metrics remain benign: card net charge-off rate guidance of approximately 3.4% is unchanged, and JPM opened over 450,000 net new checking accounts in Q1
The Risk:
- Expense growth of 14% year-over-year in Q1 2026 exceeded the $105 billion full-year guidance run rate; if Markets revenue normalizes, compensation-driven costs do not shrink at the same pace, compressing operating leverage
- The G-SIB surcharge reproposal adds approximately $13 billion of capital specific to JPM among large U.S. banks, potentially constraining the Markets balance sheet growth that generated the Q1 outperformance
- IB deal timing benefited from faster-than-expected regulatory approvals in Q1 according to Barnum; any reversal in the deal approval environment could shift recognized fees into future quarters
Should You Invest in JPMorgan Chase & Co.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up JPMorgan Chase stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track JPMorgan Chase alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze JPM stock on TIKR for Free →
